Market revenue in 2023 | USD 1,778.0 million |
Market revenue in 2030 | USD 5,056.4 million |
Growth rate | 16.1% (CAGR from 2023 to 2030) |
Largest segment | Functional genomics |
Fastest growing segment | Pathway Analysis |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.84% in 2023. Horizon Databook has segmented the Italy genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The advent of NGS has revolutionized the genomics industry over the years, with many innovative players entering the Italy market. One such market entity is Dante Labs, which emerged as an integral player in the Italian genomics market.
The company introduced Europe’s one-of-a-kind DTC DNA testing kits for both specific mutations as well as for performing WGS. The kits require customers to submit saliva samples (at-home service), which are later shipped for testing to the company’s office.
In addition, the company announced plans to launch new products for sequencing, more than 10,000 genomes in Europe, in the initial period of the year 2020. Furthermore, in May 2022, the company entered into a partnership with the Italian government to launch clinical genome sequencing in the healthcare system.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy genomics market , including forecasts for subscribers. This country databook contains high-level insights into Italy genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account